Inhibition of mucous metaplasia in the skin tumor keratoacanthoma by continual applications or puromycin.
D000287:Administration, Topical; D000818:Animals; D001551:Benz(a)Anthracenes; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000648:ultrastructure; D005122:Exudates and Transudates / Q000187:drug effects; D006056:Golgi Apparatus / Q000187:drug effects / Q000648:ultrastructure; D006197:Hair / Q000648:ultrastructure; D007636:Keratoacanthoma / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008679:Metaplasia / Q000517:prevention & control*; D011691:Puromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D011817:Rabbits; D014801:Vitamin A / Q000008:administration & dosage / Q000627:therapeutic use
D001551:Benz(a)Anthracenes; D014801:Vitamin A; D011691:Puromycin